4-Hydroxytamoxifen inhibits K(+) currents in mouse ventricular myocytes

Area of Science:

• Cardiology
• Pharmacology
• Molecular Biology

Background:

• Tamoxifen, a common chemotherapy, is linked to QT interval prolongation.
• Tamoxifen's cardiac effects may stem from its metabolite, 4-hydroxytamoxifen (4OH-tamoxifen).

Purpose of the Study:

• To investigate the direct impact of 4OH-tamoxifen on cardiac repolarizing potassium currents.
• To determine if 4OH-tamoxifen mediates tamoxifen's effects on cardiac repolarization.

Main Methods:

• Voltage-clamp experiments on adult mouse ventricular myocytes.
• Acute exposure to varying concentrations of 4OH-tamoxifen.
• Assessment of estrogen receptor involvement using ICI 182,780 and gene transcription inhibition with actinomycin D.

Main Results:

• 4OH-tamoxifen significantly reduced densities of I(to), I(Kur), and I(K1) potassium currents.
• No significant effect was observed on the steady-state outward K(+) current (I(ss)).
• The inhibitory effects were not mediated by estrogen receptor signaling or gene transcription.

Conclusions:

• 4OH-tamoxifen directly inhibits key cardiac potassium currents in mouse ventricular myocytes.
• The observed reduction in potassium currents by 4OH-tamoxifen is independent of estrogen receptor pathways and gene transcription.